Intralesional Voriconazole
PreclinicalSmall molecule
Intralesional Voriconazole is one of 6 small molecule programs targeting Plantar Wart. It is currently in Preclinical.
1
Indications
3
Total Trials
0
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Plantar Wart
#DrugCompanyPhaseTrials
1Blenoxane
Bristol-Myers SquibbApproved
Aldara
BBausch Health Americas, Inc.
Approved
Zovirax
BBp Consulting, Inc
Approved
Xylocaine
CCitius Pharmaceuticals, Inc.
Preclinical
Adrucil
EElorac, Inc.
Preclinical
Intralesional Voriconazole
ZZagazig University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Plantar Wart1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Intralesional Voriconazole. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- ZZagazig University